 |
|
Maximum: 1 CME cr.,
1 AutoAttendance cr.
Sign in to view your progression
|
Activity Title: COVID-19 and its causative agent, SARS-CoV-2
Release Date: February, 2021
Estimated Time to Complete Activity: 60 minutes
Statement of Need:
In this module, we will discuss the 2019 Coronavirus Disease (Covid-19) and its causative agent, SARS-CoV-2. We will also discuss the COVID-19 pandemic, the effect of COVID-19 on antimicrobial stewardship programs, vaccine developments, and measures to help prevention and contain COVID-19 infections. Information presented here is adapted from ISID’s Guide to Infection in the Healthcare Setting.
Faculty:
Professor Angelini Messi
Angeliki Messina is the Head of Antibiotic Stewardship and Clinical Pharmacy Digitisation of the Netcare Hospital Group. Her qualifications include, a B.Pharm (with distinction) obtained in 2009 and an M.Pharm completed in 2018, both from the University of the Witwatersrand. In 2015, Angeliki obtained advanced certification in antibiotic stewardship through the Making a Difference in Infectious Diseases organisation (USA)
Dr. Sean Wasserman
Dr Sean Wasserman completed his medical degree as well as post-graduate training at the University of Cape Town. He is a Fellow of the College of Physicians and Infectious Diseases at the Colleges of Medicine of South Africa. Dr Wasserman is a Consultant and Associate Professor in the Division of Infectious Diseases and HIV Medicine at Groote Schuur Hospital and the University of Cape Town.
Technical Requirements
This site and its activities are best viewed using the latest versions of the Chrome, Edge, Firefox and Safari browsers. For interactive content a broadband connection is required. For CME/CE activities featuring audio you need a sound card and speakers.
Our activities may require JavaScript to be enabled on your computer. If you are having difficulty viewing pop-up windows, click here for instructions on enabling JavaScript.
Contact Information
If you have questions about this CME activity, please contact The International Society for Infectious Diseases at info@isid.org.
For technical support issues, please contact Multilearning at support@multilearning.com
In this module, we will discuss the 2019 Coronavirus Disease and its causative agent, SARS-CoV-2.
By the end of tthis course, particpants will be able to:
- Discuss the background and etiology of the COVID-19 pandemic
- Understand the effect of COVID-19 on antimicrobial stewardship programs,
- Describe vaccine developments and measures to help prevention and contain COVID-19 infections.
The target audience for this module is physicians, nurses, public health officials, researchers, immunization officers, and other health professionals.
ProMED: Undiagnosed pneumonia - China (HU): RFI; available at https://promedmail.org/promed-post/?id=20191230.6864153
Interim Infection Prevention and Control Recommendations for Patients with Confirmed 2019 Novel Coronavirus (2019-nCoV) or Persons Under Investigation for 2019-nCoV in Healthcare Settings; available at https://www.cdc.gov/coronavirus/2019-nCoV/hcp/infection-control.html
Infection Prevention and Control During Health Care When Novel Coronavirus (nCoV) Infection is Suspected; available at https://www.who.int/publications-detail/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125
Infection Prevention and Control for the Care of Patients with 2019-nCoV in Healthcare Settings; available at https://www.ecdc.europa.eu/sites/default/files/documents/nove-coronavirus-infection-prevention-control-patients-healthcare-settings.pdf
Infection Prevention and Control of Epidemic-And Pandemic Prone Acute Respiratory Infections in Health Care. WHO guidelines 2014 [10 February 2020]; available at https://www.who.int/csr/bioriskreduction/infection_control/publication/en
Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol Generating Procedures and Risk of Transmission of Acute Respiratory Infections to Healthcare Workers: A Systematic Review. PLoS One 2012; 7(4):e35797-e; available at https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0035797
Public Health England. COVID-19: Guidance for Health Professionals [updated 2 2020]; available at https://www.gov.uk/government/collections/wuhan-novel-coronavirus
Infection Prevention and Control During Health Care When Coronavirus Disease (COVID-19) is Suspected or Confirmed; available at https://www.who.int/publications/i/item/WHO-2019-nCoV-IPC-2020.4
Coronavirus Disease 2019 (COVID-19). Duration of Isolation and Precautions for Adults with COVID-192020; available at https://www.cdc.gov/coronavirus/2019-ncov/hcp/duration-isolation.html
Disclosure Policy
In accordance with the EACCME Standards for Commercial Support, the International Society for Infectious Diseases (ISID) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. ISID resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all our educational programs. Furthermore, ISID seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. ISID is committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.
Activity Staff Disclosures:
The planners, reviewers, editors, staff, or other members at the International Society for Infectious Diseases who control content have no relevant financial relationships to disclose.
ISID Knowledge Exchange and E-Learning Platform Organizing Committee members are listed here along with Committee members’ disclosure forms.
Faculty Disclosures:
Prof. Shaheen Mehtar, Prof. Ziad A. Memish and Dr. Jaffar A. Al-Tawfiq have no actual or potential conflict of interest in relation to this program/presentation
Disclosure of Unlabeled Use
The International Society for Infectious Diseases requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. ISID does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.
Disclaimer
The International Society for Infectious Diseases presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The International Society for Infectious Diseases, and the former commercial supporter assume no liability for the information herein.
Copyright Information
Copyright © 2021 by the International Society for Infectious Diseases. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:
• The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
• Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without the International Society for Infectious Diseases' prior written permission.
Privacy Policy
The International Society for Infectious Diseases protects the privacy of personal and other information regarding participants and educational collaborators. The International Society for Infectious Diseases will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.
The International Society for Infectious Diseases maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of information that we have collected from you.
Additional information regarding the International Society for Infectious Diseases Privacy Policy and ISID’s Knowledge Exchange and E-Learning Platform Privacy Policy can be viewed at https://isid.org/privacy-policy/ and https://exchange.isid.org/isid/legal/terms-and-conditions.
|
ACCREDITED ACTIVITY
COVID-19 and It's Causative Agent, SARS-CoV-2
|
|